Spots Global Cancer Trial Database for msb0010718c
Every month we try and update this database with for msb0010718c cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Avelumab in Participants With Merkel Cell Carcinoma (JAVELIN Merkel 200) | NCT02155647 | Carcinoma, Merk... | Avelumab | 18 Years - | EMD Serono | |
Sunitinib Followed by Avelumab or the Reverse for Metastatic Renal Cell Carcinoma | NCT03035630 | Clear-cell Rena... RCC Kidney Cancer Clear-cell Kidn... | Avelumab Sunitinib | 18 Years - | Hoosier Cancer Research Network | |
Adjuvant Treatment for High-risk Triple Negative Breast Cancer Patients With the Anti-PD-l1 Antibody Avelumab | NCT02926196 | Triple Negative... | MSB0010718C | 18 Years - | Istituto Oncologico Veneto IRCCS | |
Avelumab in First-line NSCLC (JAVELIN Lung 100) | NCT02576574 | First Line Non-... | Avelumab Pemetrexed Paclitaxel Gemcitabine Gemcitabine Carboplatin Cisplatin Carboplatin Avelumab Weekly | 18 Years - | EMD Serono | |
Adjuvant Treatment for High-risk Triple Negative Breast Cancer Patients With the Anti-PD-l1 Antibody Avelumab | NCT02926196 | Triple Negative... | MSB0010718C | 18 Years - | Istituto Oncologico Veneto IRCCS | |
Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200) | NCT02395172 | Carcinoma, Non-... | Avelumab Docetaxel | 18 Years - | EMD Serono | |
Sunitinib Followed by Avelumab or the Reverse for Metastatic Renal Cell Carcinoma | NCT03035630 | Clear-cell Rena... RCC Kidney Cancer Clear-cell Kidn... | Avelumab Sunitinib | 18 Years - | Hoosier Cancer Research Network | |
Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200) | NCT02395172 | Carcinoma, Non-... | Avelumab Docetaxel | 18 Years - | EMD Serono |